| __timestamp | Evotec SE | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12404000 | 31354781 |
| Thursday, January 1, 2015 | 18343000 | 43445817 |
| Friday, January 1, 2016 | 18108000 | 66489820 |
| Sunday, January 1, 2017 | 17614000 | 96886134 |
| Monday, January 1, 2018 | 35619000 | 153793000 |
| Tuesday, January 1, 2019 | 58432000 | 148369000 |
| Wednesday, January 1, 2020 | 63945000 | 151934000 |
| Friday, January 1, 2021 | 72200000 | 198532000 |
| Saturday, January 1, 2022 | 76642000 | 112128000 |
| Sunday, January 1, 2023 | 57519000 | 76192000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, TG Therapeutics, Inc. and Evotec SE have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, TG Therapeutics, Inc. has consistently increased its R&D expenses, peaking in 2021 with a remarkable 533% increase from its 2014 levels. This upward trend underscores the company's aggressive pursuit of new therapies and treatments.
In contrast, Evotec SE's R&D spending has shown a more moderate growth, with a 463% increase over the same period. The company's strategy appears to focus on sustainable growth, balancing innovation with financial prudence.
These trends highlight the diverse approaches within the biotech sector, where strategic R&D investments can shape the future of healthcare.
Comparing Innovation Spending: Eli Lilly and Company and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and TG Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated vs Evotec SE: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.
R&D Spending Showdown: Genmab A/S vs TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
BioMarin Pharmaceutical Inc. vs TG Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
TG Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
TG Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: TG Therapeutics, Inc. and Novavax, Inc.
Viking Therapeutics, Inc. or Evotec SE: Who Invests More in Innovation?